Claude discovers a novel enzyme system with CRISPR-like repeats
Thread
Unofficial Hacker News client; not affiliated with Y Combinator.
Claude discovers a novel enzyme system with CRISPR-like repeats
Unofficial Hacker News client; not affiliated with Y Combinator.
ryanschaefer · · focus · HN ↗
I guess the improvement loop is tighter and they have more control over how discoveries can be used for marketing?
But, in my mind, it begins to feel like they are setting themselves up to be “everything” companies instead of focusing on their core product…
consumer451 · · focus · HN ↗
As an outsider, here is how I explain that behavior:
1. Truly risky models are very useful.
2. Truly risky models should not be released, according to AI safety standards. I think Antrhopic genuinely believes in AI safety. (see: standing up against automated kill chains, no matter the impacts to the company)
3. Truly risky models face regulatory pressures, if released to the public.
This all leads to "let's just do this in-house." I believe that might end up being the answer to every application of AI eventually. It seems unavoidable, and very depressing.